AGIO:NASDAQ
Agios Pharmaceuticals Inc
US$ २९.६८
arrow_downward
-०.७०%(-०.२१) 1D
US$ २९.६८
०.००% (०.००)
bedtimeAfter hours
Closed: नोभेम्बर १८, १६:००:०१ GMT-५ · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for AGIO...
Open
US$ २९.५७
High
US$ ३०.४८
Low
US$ २९.२२
Mkt. cap
१.७८ अरब
Avg. vol.
१२.१३ लाख
Volume
०.००
52-wk high
US$ ४४.०७
52-wk low
US$ २२.२४
EPS
-US$ ६.३२
Beta
०.६६
Shares outstanding
५.९८ करोड
No. of employees
५४०
Open
US$ २९.५७
High
US$ ३०.४८
Low
US$ २९.२२
Mkt. cap
१.७८ अरब
Avg. vol.
१२.१३ लाख
Volume
०.००
52-wk high
US$ ४४.०७
52-wk low
US$ २२.२४
EPS
-US$ ६.३२
Beta
०.६६
Shares outstanding
५.९८ करोड
No. of employees
५४०
News stories
From web sources and news partners
Chattanooga Times Free Press
·
३१ मिनेट पहिले
A fifth straight drop for the S&P 500 drags Wall Street to its longest losing streak since June
Benzinga
·
४४ मिनेट पहिले
Stock Market: Will S&P 500 Open Up or Down Today?
BigGo Finance
·
२ घण्टा पहिले
UBS Sets S&P 500 Target of 8,200 by End-2027, Implying Roughly 12% Upside, But Cuts Rating to Neutral
FOREX.com
·
१ घण्टा पहिले
S&P 500 Grasps At Support as Surging Hike Odds, Treasury Yields Threaten Larger Turn
Profile
Agios Pharmaceuticals Inc. is a publicly trading American pharmaceutical company pioneering therapies for genetically defined diseases, with a near-term focus on developing therapies for hemolytic anemias. The company was founded in 2008 by Lewis Cantley, Tak Mak and Craig Thompson. Agios is a Delaware corporation headquartered in Cambridge, Massachusetts. The company tendered an initial public offering in July 2013. Wikipedia
About Agios Pharmaceuticals Inc